greeksoup/ stock research
Stock research / United States / IDXX / FY2008

IDEXX Laboratories (IDXX) FY2008 results: revenue $1.0 billion

IDEXX Laboratories Inc. (IDXX) reported revenue of $1.0 billion for fiscal 2008, the year ended 31 December 2008. Net income was $116 million, and diluted earnings per share $0.94. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2011.

Revenue
$1.0 billion
FY2008FY2008
Operating margin
16.8%
FY2008FY2008
Net income
$116 million
FY2008FY2008
Diluted EPS
$0.94
FY2008FY2008

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2008Last 8 years
Revenue1,024
Cost of revenue494
Gross profit530
Gross margin51.7%
Research and development70.7
Operating income172
Operating margin16.8%
Interest expense4.6
Pre-tax income170
Income tax54.0
Effective tax rate31.7%
Net income116
Net margin11.3%
Diluted EPS$0.94
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2008Last 8 years
Operating cash flow143
Capital expenditure90.0
Free cash flow53.3
Free cash flow margin5.2%
Cash from investing-91.6
Cash from financing-30.8
Depreciation and amortisation48.0
Share-based compensation10.5
Buybacks132
Diluted shares, weighted124m

Balance sheet

$ millionFY2008Last 8 years
Shareholders' equity438
Goodwill139
Cash and equivalents78.9

10-K for the year ended 31 December 2008, filed 22 February 2011: the filing.